Fora Capital, LLC Kura Oncology, Inc. Transaction History

Fora Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$15.42 - $21.72 $20,292 - $28,583	-1,316 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$20.85 - $29.88 $27,438 - $39,322	1,316 New	1,316 $27 Million
Q1 2021 May 17, 2021	SELL	$24.75 - $39.14 $161,889 - $256,014	-6,541 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$29.0 - $41.62 $189,689 - $272,236	6,541 New	6,541 $213,000

187

81.8M

42.1K

34K

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $526M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Fora Capital, LLC with notifications on news.